121 related articles for article (PubMed ID: 38618491)
1. Baxter Physioneal, Extraneal, Nutrineal (PEN) and Dianeal solution bags can be accidentally connected to Fresenius peritoneal dialysis catheter extensions in a non-sterile manner.
Albert A; Richter S; Woitas RP; Hinkel UP; Stieger P; Braun-Dullaeus RC; Albert C
Clin Kidney J; 2024 Apr; 17(4):sfae067. PubMed ID: 38618491
[No Abstract] [Full Text] [Related]
2. Stability of drug additives in peritoneal dialysis solutions in a new container.
Voges M; Faict D; Lechien G; Taminne M
Perit Dial Int; 2004; 24(6):590-5. PubMed ID: 15559489
[TBL] [Abstract][Full Text] [Related]
3. Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.
Yung S; Lui SL; Ng CK; Yim A; Ma MK; Lo KY; Chow CC; Chu KH; Chak WL; Lam MF; Yung CY; Yip TP; Wong S; Tang CS; Ng FS; Chan TM
Perit Dial Int; 2015; 35(2):147-58. PubMed ID: 25904773
[TBL] [Abstract][Full Text] [Related]
4. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
[TBL] [Abstract][Full Text] [Related]
5. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
[TBL] [Abstract][Full Text] [Related]
7. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
8. Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.
Nguyen TT; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Zaidi STR; Patel RP
Perit Dial Int; 2020 Mar; 40(2):171-178. PubMed ID: 32063195
[TBL] [Abstract][Full Text] [Related]
9. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro.
Cooker LA; Choo CG; Luneburg P; Lamela J; Holmes CJ
Adv Perit Dial; 1999; 15():17-20. PubMed ID: 10682065
[TBL] [Abstract][Full Text] [Related]
10. Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children.
Fischbach M; Terzic J; Chauvé S; Laugel V; Muller A; Haraldsson B
Nephrol Dial Transplant; 2004 Apr; 19(4):925-32. PubMed ID: 15031351
[TBL] [Abstract][Full Text] [Related]
11. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.
de Graaff M; Zegwaard AH; Zweers MM; Vlijm A; de Waart DR; Vandemaele F; Struijk DG; Krediet RT
Perit Dial Int; 2010; 30(2):192-200. PubMed ID: 20124192
[TBL] [Abstract][Full Text] [Related]
12. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
Kussmann M; Baumann A; Hauer S; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2237-2242. PubMed ID: 28685187
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve?
Chung SH; Stenvinkel P; Bergström J; Lindholm B
Perit Dial Int; 2000; 20 Suppl 5():S57-67. PubMed ID: 11229614
[TBL] [Abstract][Full Text] [Related]
14. Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions.
Barre DE; Chen C; Cooker L; Moberly JB
Adv Perit Dial; 1999; 15():12-6. PubMed ID: 10682064
[TBL] [Abstract][Full Text] [Related]
15. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
[TBL] [Abstract][Full Text] [Related]
16. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
Chang JM; Lin SP; Lai YH; Chen HC
Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
[TBL] [Abstract][Full Text] [Related]
17. Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to Stay-Safe Balance solution: a case report.
Chan Z; Hui YH; Wong SSH
BMC Nephrol; 2022 Apr; 23(1):149. PubMed ID: 35436868
[TBL] [Abstract][Full Text] [Related]
18. Use of new peritoneal dialysis solutions in children.
Canepa A; Verrina E; Perfumo F
Kidney Int Suppl; 2008 Apr; (108):S137-44. PubMed ID: 18379537
[TBL] [Abstract][Full Text] [Related]
19. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).
Fernández-Varón E; Marín P; Espuny A; Villamayor L; Escudero E; Cárceles C
J Clin Pharm Ther; 2006 Dec; 31(6):641-3. PubMed ID: 17176370
[TBL] [Abstract][Full Text] [Related]
20. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
